Liquidia Corporation (LQDA): insider & executive buying
Liquidia Corporation · Health Care · ref. ETF XLV · price $69.94
In short — 1 insider bought Liquidia Corporation over ~6 months (1 buy, total $318k, latest May 19, 26). Public Form 4 data, informative (not a performance signal).
Are Liquidia Corporation's executives buying their own shares? Here are the disclosed insider buys over the last 6 months — a transparency data point, not an outperformance signal.
📈 1-year price
$69.94+154.7% over range
Aug 28, 25low $21.8 · high $91.03Aug 27, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Hold
No recent rating
Latest insider buys on Liquidia Corporation
| Date | Insider | Role | Shares | Amount |
|---|---|---|---|---|
| May 19, 26 | Caligan Partners LP | See Remarks, 10% | 5,300 | $318k |
⚠️ Open-market buys reported to the SEC (Form 4). Transparency data, not advice nor an outperformance signal (our backtests show no reliable edge).
Frequently asked questions
Have Liquidia Corporation's executives bought shares recently?
1 Liquidia Corporation insider(s) bought $318k over ~6 months (latest May 19, 26). A buy shows confidence, but our backtests show no performance edge.
Is insider buying a good signal for LQDA?
It's useful transparency data, but NOT a performance guarantee: our historical tests show no reliable edge from following insider buys. Cross-check with fundamentals and analyst views.
Where does this data come from?
From Form 4 filings with the SEC (mandatory for officers and 10%+ holders), aggregated and refreshed regularly.
💬 A question about Liquidia Corporation? The JPI assistant answers using our backtest data.
Keep exploring Liquidia Corporation